Bruker (BRKR) cash on hand

Cash · fiscal 2025
$298.80M

Bruker (BRKR) held cash of $298.80M at the end of fiscal 2025 (December 31, 2025). That is 62.9% higher than the $183.40M of fiscal 2024. Figures as of 18 Nov 2026, 11:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$298.80M
Change on fiscal 2024
+62.9%
Highest on record
$645.50Mfiscal 2022
Lowest on record
$183.40Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $645.50M in fiscal 2022 and the lowest $183.40M in fiscal 2024.

History · 4 fiscal years

Cash by fiscal year

Bruker cash on hand, year by year

Bruker (BRKR) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$298.80M 62.9% up
2024$183.40M 62.4% down
2023$488.30M 24.4% down
2022$645.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Bruker and comparable companies
CompanyCashFiscal year
Spyre Therapeutics SYRE$756.53M2025
Qiagen QGEN$1.10B2025
Insulet PODD$716.10M2025
Bruker BRKR$298.80M2025
Globus Medical GMED$557.24M2025
Madrigal Pharmaceuticals MDGL$983.56M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker cash on hand: questions and answers

How much cash does Bruker have?

Bruker (BRKR) held cash of $298.80M at the end of fiscal 2025 (December 31, 2025). That is 62.9% higher than the $183.40M of fiscal 2024.

What are the highest and lowest cash figures on record for Bruker?

Across the 4 fiscal years on record (2022–2025), the highest was $645.50M in fiscal 2022 and the lowest $183.40M in fiscal 2024.

How is Bruker's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Bruker it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/BRKR/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.